UnitedHealth Group (UNH)
(Delayed Data from NYSE)
$566.03 USD
-5.31 (-0.93%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $566.00 -0.03 (-0.01%) 7:50 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
UnitedHealth Group (UNH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$627.33 | $680.00 | $591.00 | 9.80% |
Price Target
Based on short-term price targets offered by 24 analysts, the average price target for UnitedHealth Group comes to $627.33. The forecasts range from a low of $591.00 to a high of $680.00. The average price target represents an increase of 9.8% from the last closing price of $571.34.
Analyst Price Targets (24)
Broker Rating
UnitedHealth Group currently has an average brokerage recommendation (ABR) of 1.06 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 25 brokerage firms. The current ABR compares to an ABR of 1.06 a month ago based on 24 recommendations.
Of the 25 recommendations deriving the current ABR, 23 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 92% and 8% of all recommendations. A month ago, Strong Buy made up 91.67%, while Buy represented 8.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 23 | 23 | 22 | 23 | 23 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/16/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
10/16/2024 | Truist Securities | David S Macdonald | Strong Buy | Strong Buy |
10/16/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
10/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
10/10/2024 | KeyBanc Capital Markets | Matthew Gillmor | Not Available | Strong Buy |
9/23/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/16/2024 | Mizuho SecuritiesUSA | Ann K Hynes | Strong Buy | Strong Buy |
7/18/2024 | UBS | Kevin Caliendo | Strong Buy | Strong Buy |
7/17/2024 | Argus Research Corp. | David A Toung | Not Available | Strong Buy |
7/17/2024 | Wells Fargo Securities | Stephen Baxter | Strong Buy | Strong Buy |
7/17/2024 | Not Identified | Not Identified | Hold | Strong Buy |
7/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/16/2024 | SVB Securities | Whit Mayo | Strong Buy | Strong Buy |
7/11/2024 | Cowen & Co. | Ryan Langston | Not Available | Strong Buy |
6/5/2024 | Not Identified | Not Identified | Hold | Strong Buy |
5/30/2024 | Robert W. Baird & Co. | Michael Ha | Not Available | Strong Buy |
5/1/2024 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
4/17/2024 | Piper Sandler | Jessica E Tassan | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.06 |
ABR (Last week) | 1.06 |
# of Recs in ABR | 25 |
Average Target Price | $627.33 |
LT Growth Rate | 13.00% |
Industry | Medical - HMOs |
Industry Rank by ABR | 231 of 252 |
Current Quarter EPS Est: | 6.86 |
UNH FAQs
UnitedHealth Group Incorporated (UNH) currently has an average brokerage recommendation (ABR) of 1.06 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 25 brokerage firms.
The average price target for UnitedHealth Group Incorporated (UNH) is $627.33. The current on short-term price targets is based on 15 reports.
The forecasts for UnitedHealth Group Incorporated (UNH) range from a low of $591 to a high of $680. The average price target represents a increase of $9.80 from the last closing price of $571.34.
The current UPSIDE for UnitedHealth Group Incorporated (UNH) is 9.80%
Based on short-term price targets offered by 24 analysts, the average price target for UnitedHealth Group comes to $627.33. The forecasts range from a low of $591.00 to a high of $680.00. The average price target represents an increase of 9.8% from the last closing price of $571.34.